New UK early access drugs program sets stage for wider reforms
By Nuala Moran
Monday, April 28, 2014
LONDON – The first deadline is approaching for submissions to a new UK Early Access to Medicines Scheme (EAMS), designed to support access to unlicensed or off-label drugs in areas of unmet medical need.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.